entity

TREM2, TYROBP (DAP12), PLCG2, SYK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TREM2, TYROBP (DAP12), PLCG2, SYK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
1Hypotheses
1Analyses
1Outgoing
0Incoming
1Experiments
1Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
neurodegenerationpromoted: TREM2 Agonism to Restore Microglial Phagocytosis Across Both Pathologiesdisease0.60

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2 Agonism to Restore Microglial Phagocytosis Across Both 0.735 neurodegeneration Why have anti-Aβ clinical trials failed

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why have anti-Aβ clinical trials failed despite the established role of Aβ in AD

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.741

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
E2F coordination of G2/M transcriptional program exploratory 0.750 0.00 endocycling mammalian cells proposed N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The abstract suggests that Aβ-tau synergy could explain negative results from an

closed · Rounds: 4 · Score: 0.65 · 2026-04-16

Related Research

Hypotheses and analyses mentioning TREM2, TYROBP (DAP12), PLCG2, SYK in their description or question text

No additional research found